Integrative Physiology Absence of Type VI Collagen Paradoxically Improves Cardiac Function, Structure, and Remodeling After Myocardial Infarction Short Communication

Rationale: We previously reported that type VI collagen deposition increases in the infarcted myocardium in vivo. To date, a specific role for this nonfibrillar collagen has not been explored in the setting of myocardial infarction (MI). Objective: To determine whether deletion of type VI collagen in an in vivo model of post-MI wound healing would alter cardiac function and remodeling in the days to weeks after injury. Methods and Results: Wild-type and Col6a1 / mice were subjected to MI, followed by serial echocardiographic and histological assessments. At 8 weeks after MI, infarct size was significantly reduced, ejection fraction was significantly preserved (43.9% 3.3% versus 29.1% 4.3% for wild-type), and left ventricular chamber dilation was attenuated in the Col6a1 / MI group (25.8% 7.9% increase versus 62.6% 16.5% for wild-type). The improvement in cardiac remodeling was evident as early as 10 days after MI in the Col6a1 / mice. Myocyte apoptosis within the infarcted zones was initially greater in the Col6a1 / group 3 days after MI, but by day 14 this was significantly reduced. Collagen deposition also was reduced in the infarcted and remote areas of the Col6a1 / hearts. The reductions in chronic myocyte apoptosis and fibrosis are critical events leading to improved long-term remodeling and functional outcomes. Conclusions: These unexpected results demonstrate for the first time that deletion of type VI collagen in this knockout model plays a critical protective role after MI by limiting infarct size, chronic apoptosis, aberrant remodeling, and fibrosis, leading to preservation of cardiac function. (Circ Res. 2012;110:851-856.)